Mithra Pharmaceuticals S.A.
A biotech company developing drugs for contraception, fertility, and menopause.
MITRA | BR
Overview
Corporate Details
- ISIN(s):
- BE0974283153 (+1 more)
- LEI:
- 5493002FDD273HTEKK14
- Country:
- Belgium
- Address:
- Rue Saint-Georges 5, 4000 Liège
- Website:
- https://www.mithra.com/
- Sector:
- Manufacturing
Description
Mithra Pharmaceuticals S.A. is a biotech company dedicated to women's health. The company focuses on the development, manufacturing, and commercialization of differentiated drugs and complex therapeutic solutions. Its core areas of expertise include contraception, fertility, and menopause. Mithra aims to transform the women's health sector by providing innovative choices to support and improve the overall quality of life for women.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-04-16 17:45 |
2021-04-16-Transparency-Notification-Alychlo-FR.pdf
|
French | 146.0 KB | ||
| 2021-04-15 22:30 |
MAYNE PHARMA AND MITHRA ANNOUNCE FDA APPROVAL OF NEW ORAL CONTRACEPTIVE ESTELLE®
|
English | 219.1 KB | ||
| 2021-04-15 22:30 |
MAYNE PHARMA ET MITHRA ANNONCENT L'APPROBATION PAR LA FDA DU CONTRACEPTIF ESTEL…
|
French | 187.0 KB | ||
| 2021-03-09 07:30 |
2021-03-09 Annual Results-EN.pdf
|
English | 266.0 KB | ||
| 2021-03-09 07:30 |
2021-03-09 Annual Results-FR.pdf
|
French | 295.3 KB | ||
| 2021-03-08 07:30 |
Mithra and Searchlight Pharma Announce Estelle® Approval in Canada
|
English | 211.4 KB | ||
| 2021-03-08 07:30 |
Mithra et Searchlight Pharma annoncent l’approbation d’Estelle® au Canada
|
French | 217.7 KB | ||
| 2021-02-04 07:30 |
The Board of Directors appoints Leon Van Rompay as CEO ad interim
|
English | 144.4 KB | ||
| 2021-02-04 07:30 |
Le Conseil d’administration nomme Leon Van Rompay au poste de CEO ad interim
|
French | 127.8 KB | ||
| 2021-01-21 22:00 |
Nomination of Christophe Maréchal as interim CEO
|
English | 129.3 KB | ||
| 2021-01-21 22:00 |
Nomination de Christophe Maréchal en tant que CEO ad interim
|
French | 125.2 KB | ||
| 2020-12-10 20:30 |
Mithra announces final terms of its offering of EUR 125 million convertible bon…
|
English | 163.7 KB | ||
| 2020-12-10 20:30 |
Mithra annonce les termes définitifs de son offre d'obligations convertibles d'…
|
French | 171.1 KB | ||
| 2020-12-10 17:30 |
Mithra announces placement of EUR 125 million convertible bonds due 2025
|
English | 177.3 KB | ||
| 2020-12-10 17:30 |
Mithra annonce un placement d'obligations convertibles d'un montant de EUR 125 …
|
French | 187.4 KB |
Automate Your Workflow. Get a real-time feed of all Mithra Pharmaceuticals S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Mithra Pharmaceuticals S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Mithra Pharmaceuticals S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-01-17 | NOSHAQ SA | Board | Other | 172,574 | 617,814.92 EUR |
| 2022-11-17 | NOSHAQ SA | Board | Other | 172,574 | 1,052,701.40 EUR |
| 2022-07-18 | NOSHAQ SA | Board | Other | 156,250 | 1,006,250.00 EUR |
| 2022-05-13 | NOSHAQ SA | Board | Other | 156,250 | 1,239,062.50 EUR |
| 2022-04-13 | Gordenne Valérie | Other | Sell | 8,500 | 87,380.00 EUR |
| 2022-03-29 | Fornieri Francesco | Board | Sell | 100,000 | 1,312,000.00 EUR |
| 2022-03-25 | Fornieri Francesco | Board | Sell | 35,893 | 486,530.57 EUR |
| 2022-03-24 | Fornieri Francesco | Board | Sell | 15,657 | 219,536.19 EUR |
| 2022-03-24 | Fornieri Francesco | Board | Sell | 2,818 | 39,452.00 EUR |
| 2022-03-23 | Fornieri Francesco | Board | Sell | 12,525 | 178,230.75 EUR |
Peer Companies
